Development and validation of a method for the determination of 5‑fluorouracil in a polymer complex based on polymethacrylic acid using UV spectroscopy
Patient-Oriented Medicine and Pharmacy · 21.07.2026 · 4 (2) · 5-15
DOI: 10.37489/2949-1924-0136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Patient-Oriented Medicine and Pharmacy, online erschienen am 21.07.2026. Verfasst von O. V. Zhukova und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
5-fluorouracil (5-FU) is a basic chemotherapeutic agent, but its clinical use is limited by rapid metabolism and high toxicity. The development of controlled release systems based on polymethacrylic acid (PMAA) allows for an improved pharmacokinetic profile of the drug, which requires validation of analytical methods for the resulting compound to ensure the quality requirements of such polymer systems.
Objective
Development and validation of a method for the quantitative determination of 5-FU in a PMAA based polymer complex using UV spectroscopy in various media simulating biological conditions. Materials and methods. The object of the study was a lyophilized polymer complex of 5-FU and PMAA, obtained by liquid phase synthesis. The analysis was performed by UV spectroscopy on a Shimadzu UV-1800 instrument at a wavelength of 265–267 nm. The method was validated in accordance with the State Pharmacopoeia XV for the following parameters: specificity, linearity, accuracy, repeatability, and intralaboratory precision (with the participation of two operators). The studies were conducted in three media: purified water, phosphate buffer (pH 7.4 blood) and citrate buffer (pH 5.1 intracellular medium).
Results
Complex formation via hydrogen bonds between 5-FU and the carboxyl groups of PMAA was confirmed. The method was deemed specific, as the polymer carrier does not absorb in the analytical range (265 nm). A linear relationship was established (R[2] > 0.999). The recovery rate (accuracy) ranged from 98.48 % for a citrate buffer solution to 99.23 % for a phosphate buffer solution. The coefficient of variation (RSD) during precision testing did not exceed 2 %, confirming that the proposed method has satisfactory repeatability (convergence) and ensures reproducible results with multiple sample analyses under identical conditions. Calculated Student's and Fisher's t-tests confirmed the absence of systematic errors between operators. The study revealed that in an acidic environment (pH 5.1), the release of 5-FU was 15.92 % higher than at pH 7.4, confirming the pH sensitivity of the system.
Conclusions
The developed spectrophotometric method fully meets validity requirements and can be used for quality control of PMAA based polymeric 5-FU delivery systems. The demonstrated selectivity of 5-FU release in an acidic environment confirms the potential of using polymeric complexes for targeted delivery to tumor tissue.
Zitieren
APA
Zhukova, O. V., Dubovskaya, N. A., & Khokhlov, A. L. (2026). Development and validation of a method for the determination of 5‑fluorouracil in a polymer complex based on polymethacrylic acid using UV spectroscopy. Patient-Oriented Medicine and Pharmacy, 4(2), 5-15. https://doi.org/10.37489/2949-1924-0136
Vancouver
Zhukova OV, Dubovskaya NA, Khokhlov AL. Development and validation of a method for the determination of 5‑fluorouracil in a polymer complex based on polymethacrylic acid using UV spectroscopy. Patient-Oriented Medicine and Pharmacy. 2026;4(2):5-15. doi:10.37489/2949-1924-0136
BibTeX
@article{Zhukova2026,
author = {Zhukova, O. V. and Dubovskaya, N. A. and Khokhlov, A. L.},
title = {Development and validation of a method for the determination of 5‑fluorouracil in a polymer complex based on polymethacrylic acid using UV spectroscopy},
journal = {Patient-Oriented Medicine and Pharmacy},
year = {2026},
volume = {4},
number = {2},
pages = {5--15},
doi = {10.37489/2949-1924-0136}
}
EUVIMED